372 related articles for article (PubMed ID: 27476706)
1. The Diagnosis and Treatment of Multiple Myeloma.
Gerecke C; Fuhrmann S; Strifler S; Schmidt-Hieber M; Einsele H; Knop S
Dtsch Arztebl Int; 2016 Jul; 113(27-28):470-6. PubMed ID: 27476706
[TBL] [Abstract][Full Text] [Related]
2. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
[No Abstract] [Full Text] [Related]
3. [Therapy of multiple myeloma. What is confirmed?].
Peest D; Ganser A; Einsele H
Internist (Berl); 2013 Dec; 54(12):1434, 1436-8, 1440-2. PubMed ID: 24201762
[TBL] [Abstract][Full Text] [Related]
4. [Multiple myeloma. Diagnosis and therapy].
Goldschmidt H; Cremer FW; Möhler TM; Ho AD
Internist (Berl); 2003 May; 44(5):599-600, 603-16; quiz 617-8. PubMed ID: 12966788
[TBL] [Abstract][Full Text] [Related]
5. [State of the art treatment of progressive or refractory multiple myeloma].
Schmidt-Wolf IG; Straka C; Scheid C; Einsele H; Goldschmidt H; Engelhardt M
Dtsch Med Wochenschr; 2014 Oct; 139(41):2091-5. PubMed ID: 25268212
[TBL] [Abstract][Full Text] [Related]
6. Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.
Talley PJ; Chantry AD; Buckle CH
Br Med Bull; 2015 Mar; 113(1):15-30. PubMed ID: 25662536
[TBL] [Abstract][Full Text] [Related]
7. Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?
Mian HS; Wildes TM
Drugs Aging; 2018 Apr; 35(4):289-302. PubMed ID: 29557059
[TBL] [Abstract][Full Text] [Related]
8. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
Kumar SK; Callander NS; Alsina M; Atanackovic D; Biermann JS; Chandler JC; Costello C; Faiman M; Fung HC; Gasparetto C; Godby K; Hofmeister C; Holmberg L; Holstein S; Huff CA; Kassim A; Liedtke M; Martin T; Omel J; Raje N; Reu FJ; Singhal S; Somlo G; Stockerl-Goldstein K; Treon SP; Weber D; Yahalom J; Shead DA; Kumar R
J Natl Compr Canc Netw; 2017 Feb; 15(2):230-269. PubMed ID: 28188192
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
[TBL] [Abstract][Full Text] [Related]
10. Current and emerging treatments for multiple myeloma.
Schwartz RN; Vozniak M
J Manag Care Pharm; 2008 Sep; 14(7 Suppl):12-9. PubMed ID: 18774881
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management.
Rajkumar SV
Am J Hematol; 2013 Mar; 88(3):226-35. PubMed ID: 23440663
[TBL] [Abstract][Full Text] [Related]
12. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
Awedan AA
Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
[TBL] [Abstract][Full Text] [Related]
13. Stem cell transplantation for multiple myeloma.
Gasparetto C
Cancer Control; 2004; 11(2):119-29. PubMed ID: 15024348
[TBL] [Abstract][Full Text] [Related]
14. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
Malard F; Harousseau JL; Mohty M
Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of multiple myeloma.
Kyle RA
Hematology; 2012 Apr; 17 Suppl 1():S125-8. PubMed ID: 22507799
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic approach for relapsed/refractory multiple myeloma: the logic and practice].
Kuroda J
Rinsho Ketsueki; 2017; 58(10):2058-2066. PubMed ID: 28978849
[TBL] [Abstract][Full Text] [Related]
17. Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.
Gimsing P; Carlson K; Turesson I; Fayers P; Waage A; Vangsted A; Mylin A; Gluud C; Juliusson G; Gregersen H; Hjorth-Hansen H; Nesthus I; Dahl IM; Westin J; Nielsen JL; Knudsen LM; Ahlberg L; Hjorth M; Abildgaard N; Andersen NF; Linder O; Wisløff F
Lancet Oncol; 2010 Oct; 11(10):973-82. PubMed ID: 20863761
[TBL] [Abstract][Full Text] [Related]
18. Advances in biology and therapy of multiple myeloma.
Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
[TBL] [Abstract][Full Text] [Related]
19. Response evaluation and monitoring of multiple myeloma.
Fernández de Larrea C; Delforge M; Davies F; Bladé J
Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347
[TBL] [Abstract][Full Text] [Related]
20. State of the art therapy in multiple myeloma and future perspectives.
Denz U; Haas PS; Wäsch R; Einsele H; Engelhardt M
Eur J Cancer; 2006 Jul; 42(11):1591-600. PubMed ID: 16815703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
